HIGHLIGHTS
- who: Kejia Zhao and collaborators from the Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University have published the research work: HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances, in the Journal: Biomolecules 2023, 601 of 27/03/2023
- how: All these data indicated that PES and its derivatives might be superior anti-cancer compounds.
- future: It is important to focus on the binding mechanism of these compounds with HSP70 in future studies. The in_vivo anti-tumor effect of YK5 still remains to be verified and relevant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.